Tesla, Inc. (NASDAQ:TSLA) is one of the Trending AI Stocks in Focus This Week. On July 16, Baird reiterated the stock as ...

Tesla Inc. (NASDAQ: TSLA) heads into next week's earnings report with a lot riding on the outcome. Shares have surged as much ...

Anticipating a weak Tesla, Inc. Q2 and potential selloff, we highlight key updates that could boost TSLA sentiment. Click ...

Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than ...

Johnson & Johnson shares fell slightly Thursday after soaring yesterday amid investor optimism about the company's ...

Tesla enters Q2 2025 at a critical juncture, balancing short-term earnings pressure with long-term growth potential driven by expansion in China and India.

UBS noted the stock's valuation has re?rated about 20% since March and now embeds much of the expected acceleration in ...

Jefferies upgraded Abbott Laboratories (NYSE:ABT) to Buy from Hold, calling the market reaction to the company’s latest results “too punitive” and arguing that near-term headwinds in diagnostics are ...

Earnings are expected to be around $0.44 per share, according to consensus estimates, reflecting a 15% drop compared to the ...

Elon Musk's Tesla didn't sell its Bitcoin holdings, the firm reported in its latest quarterly earnings report.

Tesla (NASDAQ: TSLA) stock got hit with a substantial valuation pullback in Tuesday's trading. The electric vehicle (EV) leader's share price ended the daily session down 5%. Meanwhile, the S&P 500 ...

After soaring in 2023 and 2024, shares of Tesla (NASDAQ:TSLA) were battered throughout Q1 2025. And while the stock performed marginally better in Q2, the largest U.S. EV-maker slid into Q3. Over the ...